Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G10339FR
Summary
- GlyTouCan ID
-
G10339FR
- Subsumption Level
- Base composition
- Monoisotopic Mass
- 1421.52
External Links
- GlyGen
3D Structures
- GlycoShape
- G10339FR
Organisms
Taxonomic Hierarchy
Core Protein
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| O60486 | Plexin-C1 | ||
| P01033 | Metalloproteinase inhibitor 1 | ||
| P01591 | Immunoglobulin J chain | ||
| P01857 | Immunoglobulin heavy constant gamma 1 | ||
| P01861 | Immunoglobulin heavy constant gamma 4 | ||
| P01871 | Immunoglobulin heavy constant mu | ||
| P02751 | Fibronectin | ||
| P05090 | Apolipoprotein D | ||
| P0DTC2 | Spike glycoprotein | ||
| P23435 | Cerebellin-1 |
Sequence Descriptors
- WURCS
- WURCS=2.0/3,8,7/[uxxxxm][uxxxxh_2*NCC/3=O][uxxxxh]/1-2-2-2-3-3-3-3/a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?_a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?_a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?_a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?_a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?_a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?_a?|b?|c?|d?|e?|f?|g?|h?}-{a?|b?|c?|d?|e?|f?|g?|h?
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 34004174 | Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells | Parker R | 2021 May 25 |
|
| 33077685 | Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins | Zhang Y | 2021 |
|
| 33135055 | Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 | Shajahan A | 2020 Oct 29 |
|
| 32841605 | Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Zhao P | 2020 Oct 07 |
|
| 33064451 | Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry | Wang D | 2020 Nov 3 |
|
| 32366695 | Site-specific glycan analysis of the SARS-CoV-2 spike | Watanabe Y | 2020 May 4 |
|
| 32518941 | Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics | Zhou D | 2020 Jun 10 |
|
| 29671580 | Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and alpha-1B-Glycoprotein | Sun S | 2018 Apr 19 |
|
| 26791533 | N-Glycoproteomics of Human Seminal Plasma Glycoproteins | Saraswat M | 2016 Mar 4 |
|
| 24766575 | Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis | Liu M | 2014 Jun 6 |
|
